Association of IFN-γ and IFN regulatory factor 1 polymorphisms with childhood atopic asthma - 03/09/11
Abstract |
Background: IFN-γ and related molecules play important roles in the differentiation and function of TH2 cells. Objective: We sought to determine whether IFNG and related genes contribute to any susceptibility to atopic asthma, a representative TH2-dominant disorder. Methods: We investigated the association of IFNG (CA repeat polymorphism within the first intron), IRF1 (GT repeat polymorphism within the intron 7), IFNGR1 (Val 14 Met), and IFNGR2 (Gln 64 Arg) gene polymorphisms with atopic asthma in the Japanese child population. Results: A significant association (P = .0018) was observed between IFNG gene polymorphism and atopic asthma. The tendency was more prominent in patients with age of onset of 3 years or younger (P = .0004) or patients with a family history of allergic diseases (P = .0038). Furthermore, there was a significant association between IRF1 gene whole-allele distribution and atopic asthma (P = .044). The tendency was more prominent in patients with onset at 3 years of age or less (P = .0058). On the other hand, IFNGR1 and IFNGR2 gene polymorphisms showed no association with atopic asthma. Conclusion: These results suggested that among IFNG and related genes, IFNG and IRF1 genes confer genetic susceptibility to atopic asthma in Japanese children. (J Allergy Clin Immunol 2001;107:499-504.)
El texto completo de este artículo está disponible en PDF.Keywords : IFN-γ, IFN regulatory factor 1, IFN-γ receptor, atopic asthma, polymorphism
Abbreviations : IRF-1:, SNP:
Esquema
Supported by Grant-in-Aid for Scientific Research from Ministry of Education, Science, Sports and Culture, and Health Sciences Research Grants from Ministry of Health and Welfare of Japan. |
|
Reprint requests: Futoshi Nakao, MD, Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. |
Vol 107 - N° 3
P. 499-504 - mars 2001 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?